Literature DB >> 7131038

The concentration of IgM in the cerebrospinal fluid of neurological patients.

C J Sindic, C L Cambiaso, A Depré, E C Laterre, P L Masson.   

Abstract

The level of IgM was determined by Particle Counting Immunoassay in the cerebrospinal fluid. In non-neurological patients (N = 20) the mean was 97.5 micrograms/l with the upper reference limit at 380 micrograms/l. The mean IgM index was 0.021 with the upper reference limit at 0.071. Of 21 patients with stroke, 5 had an IgM index exceeding the reference limit. High levels and indices of IgM were observed in most patients (N = 27) with infectious meningo-encephalitis. In this group, the IgM index was abnormal in about 30% of cases with a normal total protein content, and was more often increased than the IgG index. In multiple sclerosis patients (N = 80), the IgM index was increased in 32%. In this disease very high values of IgM index (greater than 0.13) were never associated with very high values of IgG index (greater than 1.8). A significantly higher proportion of males was found in the group of patients with very high values of IgM index (N = 11). No significant influence of the age of onset, the interval between onset and sampling and clinical state was observed. However, of 10 patients with a multiple sclerosis history exceeding 15 years none had an IgM index exceeding the upper reference limit. Four patients with multiple sclerosis had a high IgM index without either an increase of the IgG index or the presence of oligoclonal bands.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7131038     DOI: 10.1016/0022-510x(82)90131-9

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  8 in total

Review 1.  [Differential diagnosis of chronic inflammatory diseases of the central nervous system. Cerebrospinal fluid diagnosis and immunological parameters].

Authors:  D Reske; H-F Petereit
Journal:  Nervenarzt       Date:  2004-10       Impact factor: 1.214

2.  Cerebrospinal fluid analysis differentiates between relapsing-remitting and secondary progressive multiple sclerosis.

Authors:  P J Jongen; K J Lamers; W H Doesburg; W A Lemmens; O R Hommes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-10       Impact factor: 10.154

3.  Immune complexes in CSF and serum in various neurological diseases.

Authors:  M Cavalli; E Merelli; P Sola; G Pirrò; P Faglioni
Journal:  Ital J Neurol Sci       Date:  1986-04

4.  IgM, IgA and IgG producing cells in cerebrospinal fluid and peripheral blood in multiple sclerosis.

Authors:  A Henriksson; S Kam-Hansen; H Link
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

5.  Evaluation of immunoglobulin M western blot analysis in the diagnosis of congenital syphilis.

Authors:  L L Lewis; L H Taber; R E Baughn
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

6.  Spinal arachnoiditis due to aspergillus meningitis in a previously healthy patient.

Authors:  F A Van de Wyngaert; C J Sindic; J J Rousseau; F G Fernandes Xavier; J M Brucher; E C Laterre
Journal:  J Neurol       Date:  1986-02       Impact factor: 4.849

7.  Cerebrospinal fluid immunoglobulin abnormalities in systemic lupus erythematosus.

Authors:  J Ernerudh; T Olsson; F Lindström; T Skogh
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-08       Impact factor: 10.154

Review 8.  Remyelination-promoting human IgMs: developing a therapeutic reagent for demyelinating disease.

Authors:  A E Warrington; M Rodriguez
Journal:  Curr Top Microbiol Immunol       Date:  2008       Impact factor: 4.291

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.